Worsening weakness & numbness in a young female Flashcards

1
Q

What more Hx should you ask in a young female px with worsening weakness & numbness?

A
  • No back pain
  • No trauma
  • Symptoms not worse with cough/sneeze, Valsalva (compressive aetiology)

No systemic auto-immune disease e.g.

  • No rashes, arthralgia (SLE)
  • No miscarriages (anti-phospholipid syndrome)
  • No dry mouth, dry eyes (Sjogren’s syndrome)
  • No recent infections (Para-infectious causes, GBS)
  • No recent vaccinations (GBS)
  • Unrestricted diet (B12 deficiency)
  • No B symptoms/Paraneoplastic syndromes (malignancies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Hemisensory loss + contralateral face loss indicates the lesion is at…

A

brainstem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is the lesion for unilateral arm and leg weakness?

A

Brainstem or hemisphere.

Look for any cortical signs for hemisphere.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the pattern of lesion in patchy weakness with multiple named nerves involved?

A

Mononeuritis multiplex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pattern of lesion in variable weakness that fatigues?

A

Myasthenia gravis

If no fatigue: functional weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Compare the signs of spinal cord vs. peripheral neuropathy localisation

A

Spinal cord lesion:

  • sensory level
  • hyperreflexia
  • bowel & bladder problems

Peripheral neuropathy:

  • glove & stocking/dermatomal / single nerve distribution
  • loss of reflexes
  • no bowel & bladder problems
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the causes of SUBACUTE paraparesis?

A
  1. spinal cord:
    - multiple sclerosis
    - tumours
  2. Peripheral nerve lesions:
    - Guillain Barre syndrome (acute inflammatory demyelinating polyradiculopathy). but clasically no sensory loss. Weakness pattern usually distal in UL & proximal in LL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is Uhthoff’s phenomenon?

A

Worsening of symptoms with heat.

Reversible and stereotypic decrements in physical and cognitive symptoms due to increased ambient body temperature (including exercise, fever, summer, hot showers)

Relatively specific for Multiple sclerosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe transverse myelitis

  • definition
  • causes
A
  • Inflammatory demyelination of segment/s of spinal cord
  • Functionally transects the cord

Causes

  • Multiple Sclerosis (common)
  • Infectious/parainfectious inflammation
  • Other autoimmune disorders: vasculitis, systemic autoimmune diseases
  • No specific aetiology (40%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is clinically isolated syndrome of multiple sclerosis?

What are the common 1st Px of MS?

A

1st clinical presentation compatible with the diagnosis of MS but not fulfilling the MS diagnostic criteria

Common first presentations of MS:

  • transverse myelitis
  • optic neuritis
  • brainstem/cerebellar presentations (ataxia, nystagmus, vertigo, diplopia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you diagnose MS?

A

Affected:
-Dissemination in space in the CNS. presence of documented neurological signs in at least two parts of the CNS, e.g., transverse myelitis AND optic neuritis

  • Dissemination in time. attacks separated in time. E.g. 2 or more relapses at least 1 month apart or 2 or more of different age.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DDx of MS

A
  • neuromyelitis optica (NMO, Devic’s disease)
  • other systemic autoimmune diseases
  • acute disseminated encephalomyelitis (ADEM)
  • sarcoidosis
  • infections
  • tumours
  • conversion disorder, somatisation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can you predict the risk of a second attack of MS after the 1st one?

A

by number of inflammatory lesions on baseline MRI Brain

The presence of oligoclonal bands in the CSF confers additional risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the subtypes of MS?

A
  1. Relapsing-remitting MS (RRMS)
    - most common 90%
    - relapses w/ incomplete/complete recovery & stable phase b/w relapses
  2. Secondary progressive MS (SPMS)
    - 50-75% RR becomes SP within ~15 yrs
    - gradual neurological deterioration
    - w/ or w/o superimposed relapses
  3. Primary progressive MS (PPMS)
    - 10% overall
    - gradual but continuous neurological deterioation
    - if relapses occur: progressive + relapsing MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the MS prognosis

  • better prognosis with:
  • in general the 1/3 rules
A

Better prognosis if:

- female, young (onset before 35)
- initial sensory symptoms and optic neuritis (as opposed to motor or cerebellar dysfunction)
- initial mono-symptomatic presentation
- sudden onset, good recovery, lower attack rates, longer attack intervals

In general:
1/3 – do well without accumulating significant disability
1/3 – accumulate neurological deficits to impair activities but not serious enough to prevent them from leading a normal life
1/3 – become disabled – requiring gait/mobility aids and even high level care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the px of acute optic neuritis?

A
  • pain behind eye, worse w/ eye movement
  • reduced visual acuity
  • colour desaturation (esp red-green)
  • papilloedema on fundoscopy
17
Q

Describe a MS relapse

A

an episode of neurological disturbance consistent with MS

≥48 hours; duration: usually 2-4 weeks

not preceded by viral-like illness

≥30 days from the onset of the previous attack

usually good recovery, but residual disability may persist

18
Q

How do you Mx MS relapse? What about long term Mx of MS?

A
Acute relapse:
3-5 days of IV methylprednisolone, 1g/day
- Reduces severity of attack
- Shortens recovery time
- Effect on ultimate recovery uncertain

Long term:
Disease modifying therapy
- immunomodulatory and/or immunosuppressive effects

19
Q

Discuss the disease modifying therapies available for MS

A

immunomodulatory and/or immunosuppressive effects

1st tier:

- Interferons β (SC or IM injections 1-4/week)
- Glatiramer acetate (daily SC injections)
- Teriflunomide (daily tablet)

2nd tier:

- Fingolimod (daily tablet)
- Dimethyl fumarate (BD tablet)

3rd tier:

- Natalizumab (monthly infusion)
- Alemtuzumab (2 infusion courses over 5 years)